Author Correction: JT002, a small molecule inhibitor of the NLRP3 inflammasome for the treatment of autoinflammatory disorders

Sci Rep. 2023 Nov 16;13(1):20081. doi: 10.1038/s41598-023-47251-0.

Authors

Geza Ambrus-Aikelin¹, Katsuyuki Takeda², Anthony Joetham², Milos Lazic¹, Davide Povero^{3

4}, Angelina M Santini¹, Rama Pranadinata¹, Casey D Johnson⁵, Matthew D McGeough⁵, Federico C Beasley¹, Ryan Stansfield¹, Christopher McBride¹, Lynnie Trzoss¹, Hal M Hoffman⁵, Ariel E Feldstein⁵, Jeffrey A Stafford¹, James M Veal¹, Gretchen Bain¹, Erwin W Gelfand²

Affiliations

¹ Jecure Therapeutics, San Diego, CA, USA.
² Department of Pediatrics, National Jewish Health, Denver, CO, USA.
³ Jecure Therapeutics, San Diego, CA, USA. povero.davide@mayo.edu.
⁴ Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, USA. povero.davide@mayo.edu.
⁵ Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.

No abstract available

Publication types

Published Erratum